Chunhui Qiu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study.
Journal: Journal of hepatocellular carcinoma
Published: January 16, 2025
RAMP1 Protects Hepatocytes against Ischemia-reperfusion Injury by Inhibiting the ERK/YAP Pathway.
Journal: Journal of clinical and translational hepatology
Published: July 27, 2023
Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review.
Journal: Frontiers in oncology
Published: May 19, 2023
Retraction Notice to: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.
Journal: Molecular therapy. Nucleic acids
Published: December 26, 2022
Case Report: Cetuximab in Combination With Chemotherapy for the Treatment of Multifocal Hepatic Metastases From Colorectal Cancer Guided by Genetic Tests.
Journal: Frontiers in oncology
Published: September 30, 2020
LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.
Journal: Molecular therapy. Nucleic acids
Published: March 26, 2019
Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells.
Journal: Molecular therapy. Nucleic acids
Published: February 22, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026